Interim Manager, Application & Programming Development

Queen Mary University of London - Barts Cancer Institute

The Centre for Experimental Cancer Medicine (CECM), which is part of the Barts Cancer Institute (BCI), is comprised of a Clinical Trials Unit (CTU) which oversees the set up and coordination of all early phase investigator-led clinical trials sponsored by Barts Health or QMUL, and the Cancer Research Delivery Group(CRDG) which is responsible for recruiting patients into all trials hosted, regardless of phase, by Barts Health, coordinating trials from a site perspective and collecting data.

We are now seeking applications for an Interim Manager, Application & Programming Development, based within the CECM CTU, to provide leadership of the BCI programming team in the collection, storage, management and analysis of clinical research data. The post-holder will be responsible leading on and developing clinical trial applications to the highest standards as the BCI requires. This will include all aspects of database design, system validation and delivering an improvement plan for the continual development and management of all BCC applications. These will be mission critical projects in highly complex technical environment and applicants should therefore have experience of managing multiple, concurrent projects with other developers.

Applicants must have inappropriate computer science degree, or substantial relevant experience demonstrating development in a series of demanding work roles. Applicants will have experience of developing database solutions and contributing to clinical trial programming objectives. Authoritative knowledge of the principles, theory and practice of database design and programming and web architecture are essential. A good understanding of regulations relating to Good Clinical Practice, data protection and security are also essential.

The post is full time and fixed term for two years. Starting salary will be in the range of £36,677 - £43,152 per annum, inclusive of London Allowance. Benefits include 30 days annual leave, defined benefit pension scheme and interest-free season ticket loan.

Candidates must be able to demonstrate their eligibility to work in the UK in accordance with the Immigration, Asylum and Nationality Act 2006. Where required this may include entry clearance or continued leave to remain under the Points Based Immigration Scheme. The Centre for Cancer Prevention requires applicants to provide all certificates at interview to confirm their qualifications (as specified in the Job Description).

Informal enquiries should be addressed to Jonathan Croft at oron +44 (0)207882 3534.

Details about the school can be found at Application enquiries should be directed to

To apply, please visit the Human Resources website on and search for reference QMUL13437.

The closing date for applications is 12th June. Interviews are expected to be held shortly thereafter.

The School of Medicine and Athena SWAN Charter for Women in Science.

The School of Medicine holds a Silver Athena SWAN Award. We are committed to the equality of opportunities and to advancing women’s careers. We have policies to support staff returning from long-term absence, for flexible arrangements for staff with parental responsibilities and for childcare support. As part of the School’s commitment to the Athena SWAN principles we strongly encourage applications from women.

Valuing Diversity & Committed to Equality.

Share this job
  Share by Email   Print this job   More sharing options
We value your feedback on the quality of our adverts. If you have a comment to make about the overall quality of this advert, or its categorisation then please send us your feedback
Advert information

Subject Area(s):